Anjali Atal-Gupta, RAC (US), regulatory affairs manager, Stryker
Lisbert Avila-Yu, RAC (US), regulatory affairs associate director, BSI Group
Nikit Bhatt, BS, MS, RAC (US), senior scientist, CMC Preformulation Group, Ferring Pharmaceuticals
Sandra Binns, RAC (US), director of regulatory affairs, Glaxo Smith Kline
David Brindley, DPhil, MEng, FRSA, professor, the University of Oxford
Meredith Brown-Tuttle, RAC (US), FRAPS, vice president, regulatory and quality, Lyric Pharmaceuticals Inc.; CEO, Regulatorium
MaryEllen Dronitsky, director, regulatory affairs, advertising and promotions, Sanofi Genzyme
Selina Feng, MBS, RAC (US), regulatory affairs specialist, Athenex Inc.
Joy Frestedt, PhD, RAC (US), CPI, FRAPS, president and CEO, Frestedt Incorporated
Treena Jackson, RAC (US), quality assurance supervisor, RTI Health Solutions
Kurt Karst, JD, attorney, Hymen, Phelps & McNamara, P.C.
Julia Kim, RAC (US), director of regulatory affairs, Glaxo Smith Kline
Nicole Landreville, PEng, RAC (US), FRAPS, program manager, DGS women’s health and lunar regulatory affairs, GE Healthcare
Nisha Pandya, RAC (US), associate director, Johnson & Johnson
Mitchell Parrish, JD, RAC (US), vice president of legal affairs, Kinetiq
Anthony Schiavone, JD, legal counsel, Philips Healthcare
James Smith, DPhil candidate, the University of Oxford
Dipali Varia, MS, RAC (US), regulatory affairs associate, Heritage Pharmaceuticals Inc.
Melissa Walker, RAC (US), president and CTO, Graematter
Martha Wells, MPH, RAC (US), vice president of regulatory affairs for tissue and biologics, Dohmen Life Science Services
Andrew Zeltwanger, MS, director of regulatory and quality, Rinovum Women's Health LLC